Quintanal-Villalonga, A., Kawasaki, K., Redin, E., Uddin, F., Rakhade, S., Durani, V., Sabet, A., Shafer, M., Karthaus, W. R., Zaidi, S., Zhan, Y. A., Manoj, P., Sridhar, H., Kinyua, D., Zhong, H., Mello, B. P., Ciampricotti, M., Bhanot, U. K., Linkov, I., … Rudin, C. M. (2024). CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation. Signal Transduction and Targeted Therapy, 9(1). https://doi.org/10.1038/s41392-024-01908-y

Xu-Monette, Z. Y., Wei, L., Fang, X., Au, Q., Nunns, H., Nagy, M., Tzankov, A., Zhu, F., Visco, C., Bhagat, G., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Sun, X., Han, X., Go, H., … Young, K. H. (2022). Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical Cancer Research, 28(5), 972–983. https://doi.org/10.1158/1078-0432.ccr-21-2949